COMP <GO>
EPC vs SCL // EV/EBITDA & P/E VALUATION
Edgewell Personal Care Company (NYSE) VS. Stepan Company (NYSE) • 15-METRIC TALLY: EPC 4
— SCL 7
▲ EV/EBITDA & P/E VALUATION LEADER: SCL
LAST: $28.57 (+3.25%) • MKT CAP: $1.32B
valuation
29.4x
LAST: $69.99 (+2.31%) • MKT CAP: $1.59B
valuation
9.8x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (EPC VS. SCL)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | EPC | SCL | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.60% | 11.60% | +30.00 | EPC | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 2.50% | 4.30% | -1.80 | SCL | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 29.4x | 9.8x | +19.60 | SCL | /valuation <GO> |
| Free Cash Flow Yield | 8.99% | 1.59% | +7.40 | EPC | /fcf-yield <GO> |
| Operating Margin | 4.30% | 3.40% | +0.90 | EPC | /operating-margins <GO> |
| Net Profit Margin | 1.10% | 2.00% | -0.90 | SCL | /net-margins <GO> |
| Revenue Growth (YoY) | -1.30% | 7.00% | -8.30 | SCL | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.23% | 2.20% | +0.03 | EPC | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.58 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 55.6 | 76.2 | -20.64 | SCL | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 48.2x | 31.5x | +16.70 | SCL | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.32B | $1.59B | -$274.3M | SCL | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | EPC REV | SCL REV | EPC GROSS % | SCL GROSS % | EPC FCF | SCL FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.22B | $2.33B | 41.6% | 11.6% | $118.4M | $25.4M |
| FY 2024 | $2.25B | $2.18B | 42.4% | 12.5% | -$231.0M | $39.3M |
| FY 2023 | $2.25B | $2.33B | — | — | -$216.1M | $174.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
EPC // BETA —
SCL // BETA —